References in periodicals archive ?
Amgen's Senior Manager, Human Factor Engineering, Valerie Fenster will present a case-study on "Assessing how to reduce risks by design instead of introducing controls.
This partnership will give STI access to Detonics patents, R&D and human factors engineering talent," said Jens Krogh, STI director of sales and marketing.
Mike Horton, technical director, said: "A simple way to view human factors is to consider three aspects - job, individual and organisation.
DESCRIPTION: This book d displays current cognitive and social human factors methods that can be used to analyze individual and team performance in sport.
Using the Naval Safety Center's Human Factors Analysis and Classification System, we can identify all of the human errors that occurred.
At inception, it was envisioned that the HFG would be a living document where new guidelines would be developed as new human factors needs are identified for enhancing road users safety and as new research studies and data become available to serve as the source of guideline materials.
On the latter point, FHWA's Human Factors for Limited-Ability Autonomous Driving Systems, an EAR project, aims to investigate driver engagement through the development of limitedability autonomous driving systems.
The Human Factor Leadership Academy will focus on producing honest and compassionate leaders who will grow in positive human factor qualities that they can apply in all spheres of human endeavors.
Human Factors and Aerospace Safety is an important new international journal targeted specifically at the study of the human element in the aerospace system, and its role in either avoiding or contributing to accidents and incidents, and in promoting safe operations.
Adjibolosoo (business, Point Loma Nazarene University) presents theory and empirical evidence on the essential role of the human factor in free market efficiency and economic progress.
The first program of the collaboration will be to develop recombinant human factor VIIa as a potential treatment for hemophilia in patients with antibodies to other coagulation factors.
The 2007 cash use forecast includes planned support for completion of GTC's phase III study of ATryn([R]) in the hereditary deficiency indication for the United States, the filing of a Biologics License Application in the United States, development of the recombinant human factor VIIa production system with LFB Biotechnologies, and preclinical activities in GTC's recombinant human alpha-1 antitrypsin and CD137 monoclonal antibody programs.

Full browser ?